Pre-market trend | WuXi AppTec (2359.HK) shows bullish signals amid a significant pullback on 4/29. Can it stabilize and rebound?

At today's close, WuXi AppTec's stock price fell sharply by 3.7% to HKD 137.8, after reaching a high of HKD 144.2 during the day and then weakening throughout, ultimately closing in the lowest range of the day. The total trading volume was approximately HKD 1.58 billion, significantly larger compared to recent levels. It is noteworthy that despite the deep single-day decline in stock price, bullish signals have begun to emerge at the daily MACD level, with the convergence of DIF and DEA often indicating that the previously sustained downward momentum is marginally weakening, and the short selling pressure may be entering a phase of release. Although today's high open and low close trend is relatively weak, from a trend cycle perspective, the emergence of this bullish signal is typically regarded as one of the early characteristics of a phase bottom. On the news front, the CXO sector has recently continued to attract market attention. The expectation that the Federal Reserve will remain steady at the April FOMC meeting has basically materialized, and Powell's strong statements have further cooled market expectations for interest rate cuts, putting short-term pressure on global risk appetite. For WuXi AppTec, the rhythm of overseas customer orders and exchange rate fluctuations are the core variables affecting performance. In addition, the Hong Kong stock pharmaceutical sector has recently undergone a round of adjustments, with peers like WuXi Biologics and CanSino Biologics also showing weak performance, creating additional pressure on WuXi AppTec due to the resonance effect of capital outflows in the sector. However, as a global leader in CRO/CDMO, the company's resilience during the industry's order recovery cycle is still viewed positively by some institutions